<code id='04911E8EAC'></code><style id='04911E8EAC'></style>
    • <acronym id='04911E8EAC'></acronym>
      <center id='04911E8EAC'><center id='04911E8EAC'><tfoot id='04911E8EAC'></tfoot></center><abbr id='04911E8EAC'><dir id='04911E8EAC'><tfoot id='04911E8EAC'></tfoot><noframes id='04911E8EAC'>

    • <optgroup id='04911E8EAC'><strike id='04911E8EAC'><sup id='04911E8EAC'></sup></strike><code id='04911E8EAC'></code></optgroup>
        1. <b id='04911E8EAC'><label id='04911E8EAC'><select id='04911E8EAC'><dt id='04911E8EAC'><span id='04911E8EAC'></span></dt></select></label></b><u id='04911E8EAC'></u>
          <i id='04911E8EAC'><strike id='04911E8EAC'><tt id='04911E8EAC'><pre id='04911E8EAC'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:3192

          Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.

          advertisement

          For more on what we cover, here’s the latest on the mifepristone case; here’s where you can find Adam’s newsletter; here’s more on WuXi and Congress; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Digital health funding stays low as a new reality sets in
          Digital health funding stays low as a new reality sets in

          AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          SAMSHA loosens regulations on methadone treatment centers

          AdoseofmethadoneKevinD.Liles/APThefederalgovernmentisunveilingnewregulationsmeanttomodernizemethadon